ERBB2 and breast carcinoma: We analyzed the enrichment of open/active gene body chromatin histone marks (H2BK120ub, H3K39me3, H3K79me2), open/active promoter chromatin histone marks (H3K4me1, H3K4me3), open/active enhancer chromatin histone marks (H3K9ac, H3K27ac, H4K8ac), as well as closed/inactive promoter and enhancer chromatin histone marks (H3K9me, H3K27me3) at the ERBB2 gene chromatin in HER2-high (AU565, BT474, HCC-1954, MDA-MB-361, SKBR3) and HER2-low (MCF7, MDA-MB-231, MDA-MB-468) breast cancer cell lines.